Literature DB >> 17094924

Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next?

Ziad Nahas1, Carol Burns, Milton J Foust, Baron Short, Tal Herbsman, Mark S George.   

Abstract

Vagus nerve stimulation (VNS) therapy is the first US Food and Drug Administration-approved somatic clinical intervention for treatment-resistant depression (TRD). Long-term open data suggest a sustainable antidepressant response over time. Here we review the clinical data that exist so far and their limitations. We also discuss guidelines that may inform the clinical utilization of this procedure. Further clinical studies, in addition to prospective cost utilization and health economic investigations, are needed to better understand VNS therapy and the impact it holds on TRD care.

Entities:  

Mesh：

Year:  2006        PMID： 17094924     DOI： 10.1007/s11920-006-0049-4

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  47 in total

Review 1.  Vagus nerve stimulation. A potential therapy for resistant depression?

Authors:  M S George; H A Sackeim; L B Marangell; M M Husain; Z Nahas; S H Lisanby; J C Ballenger; A J Rush
Journal:  Psychiatr Clin North Am       Date:  2000-12

Review 2.  Treatment of mood disorders.

Authors:  Charles B Nemeroff; Michael J Owens
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

Review 3.  American health care systems and depression: the past, present, and the future.

Authors:  R M Hirschfeld
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

4.  A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

Authors:  Mark S George; A John Rush; Lauren B Marangell; Harold A Sackeim; Stephen K Brannan; Sonia M Davis; Robert Howland; Mitchel A Kling; Francisco Moreno; Barry Rittberg; David Dunner; Thomas Schwartz; Linda Carpenter; Michael Burke; Philip Ninan; Paul Goodnick
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

5.  Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression.

Authors:  Michael J Burke; Mustafa M Husain
Journal:  J ECT       Date:  2006-09       Impact factor: 3.635

6.  Vagus nerve stimulation is associated with mood improvements in epilepsy patients.

Authors:  G Elger; C Hoppe; P Falkai; A J Rush; C E Elger
Journal:  Epilepsy Res       Date:  2000-12       Impact factor: 3.045

Review 7.  Relapse and recurrence in unipolar major depression: short-term and long-term approaches.

Authors:  M E Thase
Journal:  J Clin Psychiatry       Date:  1990-06       Impact factor: 4.384

8.  Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.

Authors:  Linda L Carpenter; Francisco A Moreno; Mitchel A Kling; George M Anderson; William T Regenold; David M Labiner; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2004-09-15       Impact factor: 13.382

9.  Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures.

Authors:  E Ben-Menachem; A Hamberger; T Hedner; E J Hammond; B M Uthman; J Slater; T Treig; H Stefan; R E Ramsay; J F Wernicke
Journal:  Epilepsy Res       Date:  1995-03       Impact factor: 3.045

10.  A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Authors:  Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242
View more
  5 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

Review 2.  Vagus nerve stimulation: can it be used in adolescents or children with treatment-resistant depression?

Authors:  Zheya Jenny Yu; Ronald A Weller; Kendra Sandidge; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

3.  Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression.

Authors:  Jiliang Fang; Natalia Egorova; Peijing Rong; Jun Liu; Yang Hong; Yangyang Fan; Xiaoling Wang; Honghong Wang; Yutian Yu; Yunyao Ma; Chunhua Xu; Shaoyuan Li; Jingjun Zhao; Man Luo; Bing Zhu; Jian Kong
Journal:  Neuroimage Clin       Date:  2016-12-18       Impact factor: 4.881

4.  Neuromodulation therapies and treatment-resistant depression.

Authors:  Khalid Saad Al-Harbi; Naseem Akhtar Qureshi
Journal:  Med Devices (Auckl)       Date:  2012-07-13

Review 5.  Vagus Nerve Stimulation (VNS) and Other Augmentation Strategies for Therapy-Resistant Depression (TRD): Review of the Evidence and Clinical Advice for Use.

Authors:  Helge H O Müller; Sebastian Moeller; Caroline Lücke; Alexandra P Lam; Niclas Braun; Alexandra Philipsen
Journal:  Front Neurosci       Date:  2018-04-10       Impact factor: 4.677
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.